Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 DDAH: a target for vascular therapy?

Literature DB >> 20385710

DDAH: a target for vascular therapy?

John P Cooke.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2010 PMID： 20385710 PMCID： PMC3133479 DOI： 10.1177/1358863X10362605

Source DB: PubMed Journal: Vasc Med ISSN： 1358-863X Impact factor: 3.239

× No keyword cloud information.

25 in total

1. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.

Authors: F Abbasi; T Asagmi; J P Cooke; C Lamendola; T McLaughlin; G M Reaven; M Stuehlinger; P S Tsao
Journal: Am J Cardiol Date: 2001-11-15 Impact factor: 2.778

2. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.

Authors: V P Valkonen; H Päivä; J T Salonen; T A Lakka; T Lehtimäki; J Laakso; R Laaksonen
Journal: Lancet Date: 2001 Dec 22-29 Impact factor: 79.321

Review 3. Flow, NO, and atherogenesis.

Authors: John P Cooke
Journal: Proc Natl Acad Sci U S A Date: 2003-01-27 Impact factor: 11.205

4. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.

Authors: M C Stühlinger; P S Tsao; J H Her; M Kimoto; R F Balint; J P Cooke
Journal: Circulation Date: 2001-11-20 Impact factor: 29.690

5. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors: V Schächinger; M B Britten; A M Zeiher
Journal: Circulation Date: 2000-04-25 Impact factor: 29.690

6. Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase.

Authors: J Murray-Rust; J Leiper; M McAlister; J Phelan; S Tilley; J Santa Maria; P Vallance; N McDonald
Journal: Nat Struct Biol Date: 2001-08

7. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.

Authors: A Ito; P S Tsao; S Adimoolam; M Kimoto; T Ogawa; J P Cooke
Journal: Circulation Date: 1999-06-22 Impact factor: 29.690

8. Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.

Authors: Markus C Stühlinger; Roberta K Oka; Eric E Graf; Isabella Schmölzer; Barbara M Upson; Om Kapoor; Andrzej Szuba; M Rene Malinow; Thomas C Wascher; Otmar Pachinger; John P Cooke
Journal: Circulation Date: 2003-08-11 Impact factor: 29.690

9. Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.

Authors: Hayan Dayoub; Vinod Achan; Shanthi Adimoolam; Johannes Jacobi; Marcus C Stuehlinger; Bing-yin Wang; Philip S Tsao; M Kimoto; Patrick Vallance; Andrew J Patterson; John P Cooke
Journal: Circulation Date: 2003-11-24 Impact factor: 29.690

10. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.

Authors: Ken Y Lin; Akira Ito; Tomoko Asagami; Philip S Tsao; Shanthi Adimoolam; Masumi Kimoto; Hideaki Tsuji; Gerald M Reaven; John P Cooke
Journal: Circulation Date: 2002-08-20 Impact factor: 29.690

5 in total

1. FXR agonist INT-747 upregulates DDAH expression and enhances insulin sensitivity in high-salt fed Dahl rats.

Authors: Yohannes T Ghebremariam; Keisuke Yamada; Jerry C Lee; Christine L C Johnson; Dorothee Atzler; Maike Anderssohn; Rani Agrawal; John P Higgins; Andrew J Patterson; Rainer H Böger; John P Cooke
Journal: PLoS One Date: 2013-04-04 Impact factor: 3.240

5. Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity.

Authors: Chang-Wu Lu; Yuan Lin; Yan-Ping Lei; Lan Wang; Zhi-Min He; Yan Xiong
Journal: PLoS One Date: 2017-07-17 Impact factor: 3.240